Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 045446/0717 | |
| Pages: | 7 |
| | Recorded: | 04/05/2018 | | |
| Attorney Dkt #: | PAT057047-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15755270
|
Filing Dt:
|
02/26/2018
|
|
Publication #:
|
|
Pub Dt:
|
09/06/2018
| | | | |
|
Title:
|
COMBINATION OF RIBOCICLIB AND DABRAFENIB FOR TREATING OR PREVENTING CANCER
|
|
|
Assignee
|
|
|
|
|
| 250 MASSACHUSETTS AVENUE |
| CAMBRIDGE, MASSACHUSETTS 02139 |
|
|
Correspondence name and address
|
| |
NOVARTIS PHARMACEUTICALS CORPORATION
|
| |
ONE HEALTH PLAZA
|
| |
BUILDING 433
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
06/14/2024 04:22 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
